Is Vivos Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Vivos Inc (RDGL) is currently classified as NOT HALAL as of January 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Vivos Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Vivos Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Vivos Inc?

Muslim investors may consider investing in Vivos Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Vivos Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Vivos Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Vivos Inc updated?

The Shariah compliance status of Vivos Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Vivos Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Vivos Inc?

You can check the latest Shariah compliance status of Vivos Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

RDGL Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 15, 2025

Report Source: 2024 3rd Quarter Report

Vivos Inc. Stock Analysis RDGL

United States Health Care Nano Cap Report: Q3, 2024

Vivos, Inc. is a radiation oncology medical device company. The company is headquartered in Richland, Washington. The company went IPO on 2001-08-08. The firm has developed an Yttrium-90-based injectable Precision Radionuclide Therapy medical device to treat tumors in animals (IsoPet) and humans (RadioGel). Using the Company’s proprietary hydrogel technology, PRnT uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area. The injection delivers therapeutic radiation from within the tumor without the entrance skin dose and associated side effects of treatment that characterize external-beam radiation therapy. This feature allows the safe delivery of higher doses needed for treating non-resectable and radiation-resistant cancers. University veterinary hospitals use the IsoPet Solutions division to demonstrate animal cancers’ safety and therapeutic effectiveness. RadioGel is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor.

Key Statistics of Vivos Inc (RDGL)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.07$0.07

Today's Open

$0.07

Volume

280.94K

P/E Ratio (TTM)

52 Week Range

$0.04$0.15

Market Cap

33.16M

Avg. Volume

2.22M

Dividend Yield

Financial Metrics & Statements of Vivos Inc (RDGL)

FAQ's for Vivos Inc (RDGL)

According to Musaffa’s Shariah screening methodology, Vivos Inc (RDGL) is currently classified as NOT HALAL as of January 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.